Evaluation of plasma Chromogranin A before and after treatment with various acid inhibitors

Evaluation of plasma Chromogranin A before and after treatment with various acid inhibitors - Acid inhibitors and Chromogranin A

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019248

Enrollment

300

Registered

2015-10-14

Start date

2015-10-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acid-related gastrointestinal diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with acid-related gastrointestinal diseases, who were scheduled to treat with acid inhibitors for more than one month. 2) Patients with acid-related gastrointestinal diseases, who have been treated with acid inhibitors for more than 2 months. 3) Patients with written informed consent.

Exclusion criteria

Exclusion criteria: Patients who are not eligible for participation judged by a doctor.

Design outcomes

Primary

Measure	Time frame
Plasma Chromogranin A	—

Countries

Japan

Contacts

Public ContactNorihisa Ishimura

Shimane University Faculty of Medicine Second department of Internal Medicine

ishimura@med.shimane-u.ac.jp0853-20-2190

Outcome results